Keywords
ChemosensitizerFluoxetineMultiple drug resistancePharmacologyMedicineDrug resistanceBiologyInternal medicineGenetics
Affiliated Institutions
Related Publications
Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance
Microparticles (MPs) are released from most eukaryotic cells after the vesiculation of the plasma membrane and serve as vectors of long and short-range signaling. MPs derived fr...
Theophylline in the management of asthma: time for reappraisal?
Theophylline has been used for several decades in the treatment of asthma and remains the most widely prescribed anti-asthma drug worldwide, although the development of newer an...
Nonalcoholic Fatty Liver Disease
Insulin sensitivity (euglycemic clamp, insulin infusion rate: 40 mU · m−2 · min−1) was studied in 30 subjects with biopsy-proven nonalcoholic fatty liver disease (NAFLD), normal...
Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
Type 2 diabetes is characterized by muscle insulin resistance. Nondiabetic first-degree relatives of type 2 diabetic patients have also been reported to have insulin resistance....
Diagnosis and management of mastocytosis: an emerging challenge in applied hematology
Abstract Mastocytosis is a unique and rare neoplasm defined by abnormal expansion and accumulation of clonal mast cells (MCs) in one or multiple organ systems. Most adult patien...
Publication Info
- Year
- 2005
- Type
- review
- Volume
- 237
- Issue
- 2
- Pages
- 180-187
- Citations
- 81
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
81
OpenAlex
Cite This
Dan Peer,
Rimona Margalit
(2005).
Fluoxetine and reversal of multidrug resistance.
Cancer Letters
, 237
(2)
, 180-187.
https://doi.org/10.1016/j.canlet.2005.06.003
Identifiers
- DOI
- 10.1016/j.canlet.2005.06.003